CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
CPXX was delisted on the 11th of July, 2016.
16 hedge funds and large institutions have $6.52M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
7% more funds holding
Funds holding: 15 → 16 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less capital invested
Capital invested by funds: $7.01M → $6.52M (-$490K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
+$107K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$86.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.3K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$46.2K |
| 5 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$31.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$86K |
| 2 |
CPA
Cowen Prime Advisors
New York
|
-$41.4K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$37K |
| 4 |
Goldman Sachs
New York
|
-$29K |
CPXX Hedge Fund Activity: Q2 2015 in Review
16 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) for Q2 2015, worth a combined $6.52M — down 7% from $7.01M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CPXX positions and 5 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Nine Chapters Capital Management, opening a new position worth an estimated $107K. The largest seller was Spark Investment Management, exiting entirely with an estimated $86K sold.
- 16 institutional investors held CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) as of Q2 2015, up from 15 in Q1 2015.
- Funds reported $6.52M of CELATOR PHARMACEUTICALS INC. COMMON STOCK stock for Q2 2015, down 7% quarter-over-quarter.
- 6 funds opened new CELATOR PHARMACEUTICALS INC. COMMON STOCK positions in Q2 2015 and 5 closed out, a net change of +1 holder.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK buyer in Q2 2015 was Nine Chapters Capital Management, an estimated $107K added.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK seller in Q2 2015 was Spark Investment Management, an estimated $86K sold.
Based on aggregated 13F filings for Q2 2015.